$1.57 Billion is the total value of Eversept Partners, LP's 107 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 87.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | New | INVESCO QQQ TRput | $114,023,810 | – | 286,600 | +100.0% | 7.28% | – |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $89,844,900 | +29.2% | 833,750 | +31.4% | 5.74% | +18.9% |
| CYH | Buy | COMMUNITY HEALTH SYS INC NEW | $85,044,751 | +21.4% | 6,389,538 | +6.7% | 5.43% | +11.7% |
| DHR | Buy | DANAHER CORPORATION | $55,983,620 | +24.2% | 170,053 | +14.9% | 3.58% | +14.3% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $55,292,298 | +3.3% | 949,224 | +6.6% | 3.53% | -4.9% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $43,427,927 | – | 315,129 | +100.0% | 2.77% | – |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $38,269,368 | +12.9% | 849,298 | +4.7% | 2.44% | +3.9% |
| AZN | Buy | ASTRAZENECA PLCcall | $33,336,475 | +113.2% | 572,300 | +119.9% | 2.13% | +96.3% |
| IWM | New | ISHARES TRput | $27,806,250 | – | 125,000 | +100.0% | 1.78% | – |
| IWO | New | ISHARES TRput | $26,374,500 | – | 90,000 | +100.0% | 1.68% | – |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $25,039,082 | +62.5% | 567,205 | +41.2% | 1.60% | +49.5% |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $22,893,350 | – | 592,478 | +100.0% | 1.46% | – |
| CNC | Buy | CENTENE CORP DEL | $18,508,111 | +110.5% | 224,613 | +59.2% | 1.18% | +93.8% |
| CYH | Buy | COMMUNITY HEALTH SYS INC NEWcall | $16,999,532 | +34.9% | 1,277,200 | +18.6% | 1.09% | +24.1% |
| ANTM | Buy | ANTHEM INC | $15,896,641 | +34.8% | 34,294 | +8.4% | 1.02% | +24.1% |
| ARKG | New | ARK ETF TRcall | $14,930,312 | – | 243,800 | +100.0% | 0.95% | – |
| HQY | Buy | HEALTHEQUITY INC | $14,747,492 | +99.1% | 333,352 | +191.4% | 0.94% | +83.3% |
| XBI | New | SPDR SER TRcall | $12,741,048 | – | 113,800 | +100.0% | 0.81% | – |
| HUM | Buy | HUMANA INC | $12,719,675 | +35.5% | 27,382 | +13.7% | 0.81% | +24.7% |
| HCA | Buy | HCA HEALTHCARE INC | $12,613,230 | +35.4% | 49,094 | +28.0% | 0.81% | +24.8% |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $12,131,732 | +41.0% | 231,787 | +0.5% | 0.78% | +29.8% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $11,911,299 | +6.5% | 70,240 | +18.6% | 0.76% | -1.9% |
| ARKK | Buy | ARK ETF TRinnovation etf | $11,267,372 | +191.3% | 119,118 | +240.3% | 0.72% | +167.7% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $11,220,300 | +38.6% | 265,695 | +57.5% | 0.72% | +27.6% |
| EXEL | Buy | EXELIXIS INC | $9,792,596 | -10.3% | 535,700 | +3.8% | 0.63% | -17.4% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $9,077,477 | -20.5% | 181,151 | +1.0% | 0.58% | -26.8% |
| QGEN | Buy | QIAGEN NV | $9,033,640 | +22.1% | 162,534 | +13.6% | 0.58% | +12.5% |
| SYNH | New | SYNEOS HEALTH INCcl a | $8,790,640 | – | 85,612 | +100.0% | 0.56% | – |
| PODD | New | INSULET CORP | $8,027,864 | – | 30,172 | +100.0% | 0.51% | – |
| BIIB | New | BIOGEN INC | $7,927,197 | – | 33,041 | +100.0% | 0.51% | – |
| ARGX | Buy | ARGENX SEsponsored adr | $7,527,684 | +333.8% | 21,496 | +274.1% | 0.48% | +300.8% |
| CERN | New | CERNER CORP | $7,221,692 | – | 77,543 | +100.0% | 0.46% | – |
| LQDA | Buy | LIQUIDIA CORPORATION | $7,051,263 | +175.0% | 1,447,898 | +55.8% | 0.45% | +152.8% |
| IQV | Buy | IQVIA HLDGS INC | $6,945,723 | +327.0% | 24,618 | +262.6% | 0.44% | +292.9% |
| XENE | New | XENON PHARMACEUTICALS INC | $6,545,374 | – | 209,519 | +100.0% | 0.42% | – |
| ANAB | Buy | ANAPTYSBIO INC | $6,345,767 | +199.8% | 182,612 | +134.0% | 0.40% | +175.5% |
| SIBN | Buy | SI-BONE INC | $5,732,268 | +78.4% | 258,094 | +72.1% | 0.37% | +64.1% |
| NVRO | New | NEVRO CORP | $5,356,619 | – | 66,074 | +100.0% | 0.34% | – |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $5,309,482 | – | 63,163 | +100.0% | 0.34% | – |
| MRK | New | MERCK & CO INC | $5,025,107 | – | 19,456 | +100.0% | 0.32% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $4,605,652 | – | 201,384 | +100.0% | 0.29% | – |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $3,847,025 | +46.2% | 194,589 | +21.6% | 0.25% | +34.4% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $3,530,123 | +12.9% | 9,825 | +212.4% | 0.23% | +4.1% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $3,398,410 | +21.8% | 1,117,898 | +180.9% | 0.22% | +11.9% |
| A | Buy | AGILENT TECHNOLOGIES INC | $3,102,159 | +5.5% | 19,431 | +4.1% | 0.20% | -2.9% |
| CVAC | New | CUREVAC N V | $2,916,933 | – | 85,017 | +100.0% | 0.19% | – |
| PGNY | New | PROGYNY INCput | $2,517,500 | – | 50,000 | +100.0% | 0.16% | – |
| GRTS | New | GRITSTONE BIO INC | $2,187,808 | – | 170,125 | +100.0% | 0.14% | – |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $2,176,880 | +31.5% | 14,840 | +58.6% | 0.14% | +20.9% |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $2,083,993 | -20.1% | 401,540 | +0.9% | 0.13% | -26.5% |
| ACAD | New | ACADIA PHARMACEUTICALS INCcall | $1,974,564 | – | 84,600 | +100.0% | 0.13% | – |
| ESTA | New | ESTABLISHMENT LABS HLDGS INC | $1,699,010 | – | 25,137 | +100.0% | 0.11% | – |
| UTHR | New | UNITED THERAPEUTICS CORP DELcall | $1,642,208 | – | 7,600 | +100.0% | 0.10% | – |
| RGEN | Buy | REPLIGEN CORP | $1,214,027 | -4.6% | 4,584 | +4.1% | 0.08% | -11.4% |
| MIST | Buy | MILESTONE PHARMACEUTICALS IN | $963,931 | +48.6% | 147,165 | +29.6% | 0.06% | +37.8% |
| VCRA | New | VOCERA COMMUNICATIONS INC | $970,655 | – | 14,970 | +100.0% | 0.06% | – |
| MRUS | New | MERUS N V | $604,200 | – | 19,000 | +100.0% | 0.04% | – |
| CSU | New | SONIDA SENIOR LIVING INC | $433,304 | – | 15,209 | +100.0% | 0.03% | – |
| BKD | New | BROOKDALE SR LIVING INC | $408,393 | – | 79,146 | +100.0% | 0.03% | – |
| JYNT | New | JOINT CORPput | $361,295 | – | 5,500 | +100.0% | 0.02% | – |
| MNKD | New | MANNKIND CORPcall | $218,500 | – | 50,000 | +100.0% | 0.01% | – |
| GLYC | New | GLYCOMIMETICS INC | $144,000 | – | 100,000 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.